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inherited channelopathy and acquired heart diseases such as myocardial ischaemia and heart failure (HF). [3] [4] [5] However, the mechanisms of Nav1.5 regulation under physiological and pathophysiological conditions require further investigations. The activity of Nav1.5 depends on its precise biophysical properties and the density at the plasma membrane which is balanced between forward trafficking and retrograde internalization/degradation. 6 Nav1.5 activity is further regulated by multiple factors, 7, 8 including the E3 ubiquitin ligase Nedd4-2 (neural precursor cell-expressed developmentally downregulated 4 type 2), which accelerates the degradation of Nav1.5 by ubiquitination. 9 Nedd4-2 is highly expressed in kidney and heart tissue, 10 where it downregulates target proteins such as epithelial sodium channels (ENaC), 11 human ether-a-go-go-related gene (hERG) channel 12 and Nav1.5 9 through PY (PPxY or LPxY) motif recognition by its WW domains. However, the regulation of Nedd4-2 activity in cells is poorly understood. Interestingly, the catalytic activity of Nedd4-2 is self-inhibited via intra-or intermolecular C2 and HECT domain interaction. Elevations in intracellular calcium ([Ca   2+ ] i ) activate Nedd4-2 through binding of Ca
2+
to the C2 domain and thereby release the C2 domainmediated self-inhibition. 13 Calcium homoeostasis is tightly controlled by multiple calcium-handling proteins. Mutations or abnormal modifications of these proteins lead to aberrant calcium homoeostasis. The altered Ca 2+ handling in failing hearts, which is characterized by reduced sarcoplasmic reticulum (SR) Ca 2+ content and increased diastolic cytosolic calcium concentrations due to malfunctioned ryanodine receptor 2 (RyR2) channels, results in systolic and/or diastolic dysfunction and altered downstream signalling. 14, 15 Gene mutations of RyR2 channels, such as in RyR2-P2328S mutant mice, also exhibit increased ventricular cytosolic [Ca 2+ ] i resulting from RyR2-mediated Ca 2+ leak. 16 Thus, we hypothesized that increased cytosolic [Ca 2+ ] i -mediated activation of Nedd4-2 accelerates the degradation of Nav1.5 and leads to reduced sodium current (I Na ) densities, which may provide a novel possible mechanism of Nav1.5 regulation in heart failure. 2+ ] i downregulates Nav1.5 and I Na
Results

Increased [Ca
Cells treated with calcium ionophore, ionomycin (IM, 1 lM, Sigma-Aldrich, St. Louis, MO, USA), to increase [Ca 2+ ] i (Data S1 and Figure S1 ) were used to examine Nav1.5 expression and sodium current (I Na ) density. 24-h IM treatment significantly reduced the total Nav1.5 protein in neonatal rat cardiomyocytes (NRCMs), while 6-h IM treatment did not reduce the total Nav1.5 protein (Fig. 1a ). Both 6-h and 24-h treatments reduced Nav1.5 expression in the membrane-rich protein fraction (P < 0.05, Fig. 1a ), but did not reduce Nav1.5 mRNA level (P > 0.05, Fig. 1c ). Both 6-h and 24-h IM treatments reduced the I Na density ( Fig. 1d and e) of cardiomyocytes without altering the voltage dependence of steady-state activation and inactivation of the channels remaining at the cell membrane (Fig. 1f , Table S1 ). The sarco/endoplasmic reticulum Ca 2+ ATPase inhibitor thapsigargin (Thap, 1 lM) which was used to increase diastolic [Ca 2+ ] i 17,18 also reduced Nav1.5 protein but not its mRNA. The calcium chelator BAPTA-AM (BAP, 5 lM) restored the reduced Nav1.5 protein in NRCMs pre-treated with IM or thapsigargin comparable to a normal level (Fig. 1g) . BAP also reversed the reduced I Na pre-incubated with IM in NRCMs (Fig. 1h) . In parallel, 6-h IM treatment in Nav1.5-HEK cells exerted no effects on Nav1.5 in total protein lysates, while 24-h treatment caused a reduction of approx. 40%. Both 6-h and 24-h treatments caused a decrease of approx. 60% of Nav1.5 in the membrane-rich protein fraction (P < 0.05, Fig. 2a ) compared with the control (Ctrl), whereas it did not reduce Nav1.5 mRNA level (Fig. 2c) . Correspondingly, the peak I Na density was reduced by approx. 60% after IM treatment for 6 h (I Na density: IM 6 h À134.05 AE 16.74 vs. Ctrl À318.06 AE 36.49 pA/pF, P < 0.01) and 24 h (I Na density: IM 24 h À153.30 AE 13.76 vs. Ctrl À318.06 AE 36.49 pA/pF, P < 0.01; Fig. 2d , e, f). BAP also rescued the reduced I Na pre-treated with IM ( Figure S2 ). The voltage-dependent steady-state activation and inactivation ( Fig. 2g) as well as the recovery from fast inactivation (Fig. 2h) were not significantly altered by IM treatment (Table S2) . These results suggest that the reduced I Na density induced by ionomycin results from a decreased number of functional channels at the plasma membrane. To test the specificity of IM on Nav1.5, other ion channels were also detected. 10 In this study, IM treatment also reduced KCNQ1 protein in NRCMs. Kv4.3, the ion channel that mediates the transient outward potassium current, and Kv1.5, the ion channel that confers the ultra-rapid delayed-rectifier potassium channel currents, were not reduced in NRCMs treated by IM ( Figure S3 ).
Nedd4-2 reduces Nav1.5 protein level and I Na A GFP-Nav1.5 construct was transiently transfected into HEK 293 cells along with Nedd4-2 WT, Nedd4-2 CS (the catalytic inactive mutant, Cys 801 mutated to Ser) or empty pcDNA3 vector to record I Na (Fig. 3) . WT Nedd4-2 decreased the peak I Na density by approx. 42% compared with the empty vector (I Na density: pcDNA3 À378.55 AE 57.60 vs. Nedd4-2 À218.39 AE 34.57 pA/pF, P < 0.05; Fig. 3b ), whereas Nedd4-2 CS did not significantly affect the I Na density (I Na density: pcDNA3 -378.55 AE 57.60 vs. Nedd4-2 CS À315.53 AE 39.59 pA/pF, P > 0.05; Fig. 3b ). In addition, Nedd4-2 co-transfection reduced Nav1.5 expression level by approx. 40% (P < 0.05, Fig. 3d ), while Nedd4-2 CS co-transfection did not significantly reduce Nav1.5 expression (P > 0.05, Fig. 3d ). Co-IPs were used to further test the interaction between these two proteins. HEK 293 cells were co-transfected with Nav1.5 and Nedd4-2 or Nedd4-2 CS plasmids together with incubation of proteinase inhibitor MG132 for 24 h. Then, the cells were harvested and immunoprecipitated by anti-Nav1.5 antibody, and the precipitated fractions were immunoblotted using anti- ] i decreased Nav1.5 protein and I Na in NRCMs. NRCMs were treated with ionomycin (IM, 1 lM) or thapsigargin (Thap, 1 lM) to increase [Ca 2+ ] i . (a), Representative immunoblot and (b) densitometric measurements (normalized to actin) of Nav1.5 in total protein (TP) and membrane protein (MP) extracts in NRCMs treated without (Ctrl) or with IM for 6 h or 24 h. n = 3, *P < 0.05 vs. Ctrl. (c) The SCN5A mRNA level in NRCMs (normalized to GAPDH), n = 3. (d), Typical I Na current traces in NRCMs cells treated without IM (Ctrl) or with IM for 6 h (IM 6 h) or 24 h (IM 24 h). (e), The I/V curve of the summarized I Na . n = 10~14 cells, *P < 0.05 vs. Ctrl. (f), Steady-state activation and inactivation curves. Activation properties were determined from I/V relationships, and the normalized conductance was plotted against membrane voltage. Inactivation properties were estimated by normalized peak currents plotted against membrane voltage. Steady-state activation and inactivation curves were fitted with the Boltzmann equation. NRCMs were pre-treated with IM or Thap for 6 h; then, BAPTA-AM (BAP, 5 lM) was added for further incubation of 24 h. Then, the cells were harvested for Western blot analysis to detect Nav1.5 protein level or for patch clamp study to record I Na . (g) The densitometric measurements of Nav1.5 to actin were presented below the representative immunoblot (n = 3, *P < 0.05 vs. Ctrl, # Nav1.5 and anti-Nedd4-2 antibodies respectively. The ratio of Nedd4-2/Nav1.5 represents the bound efficiency between these two proteins. The results show that Nedd4-2 bound to Nav1.5 much more efficiently than Nedd4-2 CS did ( Fig. 3e and f (Fig. 4c) . The Co-IP assay was used to investigate the effect of calcium on Nedd4-2 and Nav1.5 interactions as well as Nav1.5 ubiquitination level. HEK 293 cells transfected with Nav1.5 together ] i for 6 h or 24 h; then, the cell were harvested for further analysis. (a), Representative immunoblot and (b) densitometric measurements (normalized to actin) of Nav1.5 in total protein (TP) and membrane protein (MP) extracts of Nav1.5-HEK cells. n = 3, *P < 0.05 vs. Ctrl. (c), The SCN5A mRNA level in Nav1.5-HEK cells (normalized to GAPDH), n = 3. (d), Typical I Na current traces in Nav1.5-HEK cells treated with IM for 6 h (IM 6 h) and 24 h (IM 24 h) or without IM (control, Ctrl). (e), The summarized peak I Na density. n = 12~13 cells, with pcDNA3, HA-tagged Nedd4-2 or HA-tagged Nedd4-2 CS were treated without (Ctrl) or with IM in the presence of MG132 (proteasome inhibitor). As shown in Figure 4d and e, IM treatment robustly increased Nedd4-2/Nav1.5 ratio in Nedd4-2-or Nedd4-2 CS-transfected cells, immunoprecipitated by antiNav1.5 antibody, and the Nav1.5/Nedd4-2 ratio, immunoprecipitated by anti-HA tag antibody. In addition, Nav1.5 ubiquitination level under IM treatment was further tested. HEK 293 cells transiently transfected with Nav1.5-WT together with Nedd4-2 or Nedd4-2 CS were immunoprecipitated (IP) by antiubiquitin antibody and then immunoblotted (IB) with anti-Nav1.5 antibody to test the ubiquitinated Nav1.5. As shown in Figure 4f , compared with Nedd4-2 WT co-transfection, a robust decrease in incorporated ubiquitin was observed in Nedd4-2 CSco-transfected cells ( # P < 0.05 vs. Nedd4-2), and IM treatment significantly increased Nav1.5 ubiquitination level in Nedd4-2 but not in Nedd4-2 CS-co-transfected cell (*P < 0.05 vs. Nedd4-2). These results suggest that elevated [Ca 2+ ] i increases Nedd4-2 expression and the interaction between Nav1.5 and Nedd4-2 and consequently increases Nav1.5 ubiquitination.
Calcium downregulates Nav1.5 via Nedd4-2 pathway Nav1.5-HEK cells were transfected either with Nedd4-2, Nedd4-2 CS or pcDNA3 for 24 h and then Figure 3 Nedd4-2-WT, but not Nedd4-2 CS, interacts with Nav1.5 and decreases Nav1.5 in HEK 293 cells expressing Nav1.5.
(a), Representative I Na current traces were obtained from HEK 293 cells co-transfected with GFP-SCN5A plus pcDNA3, Nedd4-2-WT or Nedd4-2 CS. (b), The peak I Na density is summarized in the bar graphs. n = 6~10 cells, *P < 0.05 vs. pcDNA3. Representative immunoblot (c) and (d) densitometric measurements (normalized to actin) of Nav1.5 in Nav1.5-HEK cells transfected with pcDNA3, Nedd4-2-WT or Nedd4-2 CS, n = 3, *P < 0.05 vs. pcDNA3. HEK 293 cells were transfected with Nav1.5 and Nedd4-2 or Nedd4-2 CS plasmids together with MG132 incubation for 24 h. The cell lysates were then immunoprecipitated (IP) with antiNav1.5 or anti-GAPDH (as a negative control) antibody to precipitate Nav1.5 and its associated proteins; then, the precipitated fractions were separately immunoblotted (IB) using anti-Nav1.5 and anti-Nedd4-2 antibody as indicated. Input of the precipitation experiments is presented as a control of Nav1.5 and Nedd4-2 expression. The representative immunoblot (e) and (f) densitometric measurements (Nedd4-2/Nav1.5 ratio) of Nav1.5 and Nedd4-2, n = 3, † P < 0.01 vs. Nedd4-2.
treated without (Ctrl) or with IM for 6 h to increase [Ca 2+ ] i . In line with the previous results in Figure 2a , as illustrated in Figure 5a , Nav1.5 expression was not significantly reduced by 6-h IM treatment in pcDNA3-transfected (P > 0.05) or Nedd4-2 CS-transfected cells (P > 0.05), but was significantly reduced in Nedd4-2-transfected cells (P < 0.05). The previous studies demonstrated that Y1977A mutation disrupts the conserved amino acids of PY motif (PPxY) in Nav1.5 and abolished the interaction with Nedd4-2 WW domain.
Consequently, the expression and function of Y1977A-Nav1.5 were not affected by Nedd4-2. 9,21 To further assess whether IM-decreased Nav1.5 was dependent on Nedd4-2-Nav1.5 interaction, the Y1977A-Nav1.5 mutant was constructed. As anticipated, 24-h IM treatment reduced Nav1.5 in HEK 293 cells transiently transfected with WT-Nav1.5 but not with Y1977A-Nav1.5 mutant (Fig. 5c, d ). In addition, the Y1977A mutation abolished the Nedd4-2 overexpression-mediated decrease in Nav1.5 Figure 4 Calcium-increased Nedd4-2 expression, Nedd4-2 and Nav1.5 interaction, and Nav1.5 ubiquitination level. (a), Representative immunoblots and (b) densitometric measurements (normalized to actin) of Nedd4-2 expression in whole-cell lysates from Nav1.5-HEK cells or NRCMs cells treated either with ionomycin (IM) or thapsigargin (Thap) for 6 h, n = 3, *P < 0.05 vs. Ctrl. (c), mRNA level of Nedd4-2 (normalized to GAPDH) in NRCMs treated with IM or Thap, n = 3, *P < 0.05 vs. Ctrl. HEK 293 cells transfected by Nav1.5 together with pcDNA3, HA-tagged Nedd4-2 or HA-tagged Nedd4-2-CS were treated without (Ctrl) or with IM in the presence of MG132 (proteasome inhibitor) for Co-IP assay presented in (d), (e) and (f).
(d), The whole-cell lysates were immunoprecipitated (IP) with anti-Nav1.5 and immunoblotted (IB) with anti-Nav1.5 and/or anti-Nedd4-2 antibody, respectively, to detect the bound Nedd4-2 by Nav1.5. The densitometric measurements (Nedd4-2/ Nav1.5 ratio) were presented below the representative blots (n = 3, *P < 0.05 vs. Ctrl, # P < 0.05 vs. Nedd4-2). (e) The cell lysates were immunoprecipitated by anti-HA antibody and immunoblotted against Nav1.5 and/or Nedd4-2, and the densitometric measurements (Nav1.5/Nedd4-2 ratio) were presented below the representative blots (n = 3, *P < 0.05 vs. Ctrl, # P < 0.05 vs. Nedd4-2). (f) The cell lysates were immunoprecipitated by anti-ubiquitin, and the precipitates were immunoblotted using anti-Nav1.5 to detect its ubiquitination level, and the densitometric measurements (normalized to IgG) were presented below the blots (n = 3, *P < 0.05 vs. Ctrl, # P < 0.05 vs. Nedd4-2). The input proteins of cell lysates were loaded in a separate gel, and the blot indicates the same amounts of starting materials used for Co-IP. expression and also abolished IM treatment-mediated Nav1.5 reduction under Nedd4-2 transfection (Fig. 5e, f) . Nav1.5 downregulation correlates with increased Nedd4-2 expression and accompanied by increased Nav1.5 and Nedd4-2/ubiquitin co-localization in HF Rats in the HF group showed obvious clinical signs of HF, such as tachypnoea, appetite loss and lethargy. Twelve weeks after the operation, all HF rats had a significant decrease in the percentage of ejection fraction (EF) and fractional shortening (FS) and also had significant ventricular dilation compared with the SO rats based on the echocardiographic data (Table S3) , indicating successful construction of the model. Figure 6a and b shows that Nav1.5 expression declined markedly (P < 0.05), while Nedd4-2 expression was significantly increased (P < 0.01), in the HF group (n = 6) compared with the SO group (n = 6). There is no significant difference in Nav1.5 mRNA level between HF and SO rat hearts, whereas the Nedd4-2 mRNA was increased in the failing rat heart (Fig. 6c) . As Nedd4-2 is an E3 ligase that binds to target protein substrates, transferring ubiquitin from an E2-conjugating enzyme to the substrate, we investigated the co-localization of Nav1.5 and Nedd4-2/ubiquitin to elucidate the mechanism underlying Nav1.5 downregulation in HF. Figure 6d shows that Nav1.5 was distributed in a striated pattern, which is similar to the previous study, 4 while Nedd4-2 was distributed throughout the whole cell. The Nedd4-2 expression
(e) (f) Figure 5 Calcium downregulates Nav1.5 via Nedd4-2 pathway. (a), Representative immunoblot and (b) densitometric measurements (normalized to actin) of Nav1.5 in Nav1.5-HEK cells transfected with pcDNA3, Nedd4-2 or Nedd4-2 CS and treated without (Control, Ctrl) or with IM (1 lM, 6 h) as indicated. n = 3, *P < 0.05 vs. pcDNA3, # P < 0.05 vs. Nedd4-2. The representative immunoblot (c) and (d) densitometric measurements (normalized to actin) of Nav1.5 expression in Y1977A-Nav1.5 or WT-Nav1.5 transiently transfected HEK 293 cells treated with IM for 24 h., n = 3, *P < 0.05 vs. WT. The representative immunoblot (e) and (f) densitometric measurements (normalized to actin) of Nav1.5 expression in Y1977A-Nav1.5 and Nedd4-2 co-transfected HEK 293 cells and incubated without (Ctrl) or with IM., n = 3. and co-localization with Nav1.5 were increased in HF relative to SO rats, especially in the plasma membrane of adult rat cardiomyocytes. Figure 6e shows that ubiquitin was distributed throughout the cell and that its co-localization with Nav1.5 was also increased in HF. No signal above background was detected in negative-control cardiomyocytes (data are not shown).
BAPTA-AM rescues Nav1.5 in hypertrophied NRCMs induced by isoproterenol or angiotensin II NRCMs treated with isoproterenol (ISO, 10 lM) or angiotensin II (AngII, 1 lM) for 48 h were used to mimic the overactivation of the neuroendocrine system in heart failure. 22, 23 And their effects on calcium homoeostasis were studied by confocal image analysis. Similar to the previous studies, 24, 25 Figure S4 ). Similar to the failing hearts, both ISO and AngII significantly reduced Nav1.5 and increased Nedd4-2, and these effects were restored by the presence of BAP (Fig. 7a, b) . The functional role of ISO on Nav1.5 was further analysed by whole-cell patch clamp. BAP restored the macroscopic I Na (Fig. 7c) and peak I Na density (Fig. 7d) decreased by ISO. ISO did not alter the gating properties of I Na in NRCMs. Also, BAP did not significantly affect the voltage-dependent inactivation, the half maximal voltage of the steady-state activation (V 1/2 ) or the slope factor (k) (Fig. 7e and f, Table S4 ).
Discussion
The present study identifies a novel mechanism in which calcium reduces Nav1.5 expression and function through Nedd4-2-mediated ubiquitination. The major findings are as follows: (a) elevated [Ca 2+ ] i increased Nedd4-2 expression and function, in turn Figure 6 The expression and co-localization of Nav1.5 and Nedd4-2 or ubiquitin in HF rats. Representative immunoblots (a) and (b) densitometric measurements (normalized to actin) of Nav1.5 and Nedd4-2 in the SO and HF rat left ventricle tissue. n = 6 for each group, *P < 0.05 vs. SO, † P < 0.01 vs. SO. (c) The relative SCN5A and Nedd4-2 mRNA level (normalized to GAPDH) in SO and HF rat left ventricle tissue. n = 6 for each group, *P < 0.05 vs. SO. The confocal images of isolated adult rat cardiomyocytes from SO and HF groups which were double-immunolabelled with anti-Nav1.5 and Nedd4-2 antibodies (d) or with anti-Nav1.5 and ubiquitin antibodies (e).
accelerating the degradation of Nav1.5, and, as a result, downregulated the density of Nav1.5 at the plasma membrane. (b) The expression of Nedd4-2 and its co-localization with Nav1.5 were increased in failing rat hearts, which was correlated with increased ubiquitination of Nav1.5 channels.
Increased [Ca 2+ ] i reduces Nav1.5 expression via multiple mechanisms
The life cycle of Nav1.5 starts from the transcription of the SCN5A gene, mRNA processing, protein synthesis and modifications, and followed by trafficking to the plasma membrane, where it exerts its functional role, finally endocytosis from the membrane to be degraded or recycled. 1 Factors that affect any stage in this life path could result in altered Nav1.5 expression and function. A few reports have indicated that Nav1.5 mRNA and protein levels are downregulated by the calcium ionophore A23817 in neonatal rat cardiomyocytes assessed by Northern blot hybridization, 26, 27 whereas in the present study, both ionomycin and thapsigargin did not reduce Nav1.5 mRNA level, as indicated by RTqPCR. This discrepancy may due to different method used to increase calcium concentration and mRNA detection technique. In another recent study, I Na in cardiomyocytes was decreased by acutely increasing [Ca 2+ ] in the internal pipette solution in a concentrationdependent manner without modifying I Na gating properties, 28 but the mechanism is still unknown. In our case, we found that elevations of [Ca 2+ ] i by 24-h ionomycin significantly reduced Nav1.5 protein and I Na both in NRCMs and HEK 293 cells. Furthermore, IM treatment decreased I Na and reduced Nav1.5 protein in the membrane-rich fraction to a greater extent than in whole-cell lysates, which suggested that calcium was able to reduce Nav1.5 membrane density. These data indicated that besides the transcriptional regulation of Nav1.5, there exist other mechanisms underlying calcium-mediated Nav1.5 reductions.
Calcium reduces Nav1. Figure 5a and e. These results would suggest that the effect of ionomycin in NRCMs could be related to increased Nedd4-2 transcription, which is not observed in transfected cells because Nedd4-2 expression is controlled from an exogenous promoter. Calcium has been recognized as one of the most versatile second messengers, 29 which regulates expression of various genes by activation of transcription factors, including myocyte enhancer factor 2 (MEF2), GATA4 or nuclear factor of activated T cells (NFAT) in cardiomyocytes. 30, 31 However, till now, little is known about the transcription regulation of Nedd4-2, and further work will be required to determine whether the increased Nedd4-2 expression may result from calcium-activated transcription factors. Nedd4-2 ubiquitinates Nav1.5, leading to its internalization/degradation and thus reducing Na + currents without affecting forward trafficking or modifying the biophysical properties of the channel. 9, 21 In our case, the increased interaction between Nedd4-2 and Nav1.5 likely results from both increased Nedd4-2 expression and calcium-mediated Nedd4-2 activation reported by Wang et al. 13 6-h IM treatment decreased the membrane density of Nav1.5 but had no significant effect on the total expression of Nav1.5, indicating that prior to the complete degradation, the ubiquitinated Nav1.5 may be redistributed from the plasma membrane to the intracellular pool. Our data further showed that Nav1.5 protein was decreased by 6-h IM treatment in Nedd4-2-co-transfected Nav1.5-HEK cells but not in Nedd4-2 CS-or pcDNA3-co-transfected Nav1.5-HEK cells. Correspondingly, the ubiquitinated Nav1.5 level in Nav1.5-HEK cells was increased by IM treatment in Nedd4-2-co-transfected cells but not in Nedd4-2 CSco-transfected cells. Nedd4-2 was demonstrated to reduce Nav1.5 membrane density by binding to the PY motif (PPxY) in Nav1.5. Y1977A mutation in Nav1.5 disrupts the PY motif and abolished the effects of Nedd4-2 on Nav1.5. 9, 21 In our results, IM treatment exerts no effect on Y1977A-Nav1.5 in the presence or absence of Nedd4-2 co-transfection. These results demonstrate that calcium reduces Nav1.5 expression by enhancing Nedd4-2 function.
Calcium-activated Nedd4-2 mediating the downregulation of Nav1.5 may provide a novel possible mechanism of Nav1.
regulation in heart failure
Previous studies demonstrated that Nav1.5 expression is decreased in HF. 3, 4 Zicha S et al. reported that the peak sodium currents are significantly reduced in HF dog models and in human failing cardiomyocytes despite no differences in Nav1.5 mRNA levels, 32 suggesting that Nav1.5 is post-transcriptionally regulated.
The mechanisms include the expression of non-functional Nav1.5 splicing variants 23, 33 or probably the phosphorylation by Ca 2+ /CaM-dependent protein kinase II (CaMKII). 34 In the Dudley group, they found that the full length of SCN5A transcript E28A was decreased by 24.7% in HF; however, the Western Blot analysis revealed a 62.8% Nav1.5 protein reduction in HF, 35 indicating that Nav1.5 is regulated at the protein level in the failing heart. In our results, Nav1.5 protein is decreased, whereas Nav1.5 mRNA level was not reduced in the failing heart. Nedd4-2 is increased in HF accompanied by increased co-localization of Nedd4-2 and Nav1.5 heart failure by immunofluorescence assay. These data suggest that Nedd4-2 may play a role in Nav1.5 downregulation in heart failure. The failing heart is presented by increased diastolic calcium concentrations, and elevations of [Ca 2+ ] i by IM or thapsigargin increased Nedd4-2 expression and function, which suggests that the increased Nedd4-2 in HF hearts results from longterm alterations in calcium homoeostasis. Previous studies demonstrated that Nedd4-2 interacts with Nav1.5 via in vitro pull-down and yeast two-hybrid assays, but failed to co-immunoprecipitate these proteins due to their low binding affinity. 21 In the present study, although we failed to co-immunoprecipitate Nav1.5 with endogenous Nedd4-2 in heart tissue, the interaction was observed after these two proteins were overexpressed in HEK 293 cells and was indirectly reflected by immunofluorescent co-localization in isolated cardiomyocytes. Increased co-localization of Nav1.5 and ubiquitin suggests a possibility that Nedd4-2-mediated ubiquitination probably participated in Nav1.5 downregulation in HF. However, we should still acknowledge that the interaction between Nav1.5 and Nedd4-2/ubiquitin indicated by immunofluorescent co-localization could be further validated by use of knockout animals to further verify the specificity of the staining.
In vitro studies show that elevation of [Ca 2+ ] i reduced Nav1.5 protein and sodium current, and decreasing [Ca 2+ ] i by BAPTA-AM 36,37 not only restored the reduced Nav1.5 expression in hypertrophied NRCMs induced by ISO or AngII, but also increased I Na density. ISO and AngII were used to treat NRCMs to mimic the overactivation of sympathetic nervous system and rennin-angiotensin-aldosterone system in heart failure. AngII was reported to reduce I Na through H 2 O 2 -mediated transcription reduction, 38 and by activation of splice factor RBM25 and LUC7L3. 23, 39 While another report showed that the chronic AngII type 1 receptor activation reduced I Na density by about 60%, but it could not be explained by the slightly reduced Nav1.5 mRNA level, 39 these data suggest that different mechanisms are involved in AngII-mediated downregulation of I Na . Several studies have indicated that acute exposure to ISO in the bath solution enhanced Na + conductance. 40, 41 In a recent study, mouse cardiomyocytes exposed to ISO acutely reduced the membrane distribution of Nav1.5, but increased the peak I Na by negatively shifting I Na activation. 42 However, the chronic effects of ISO on Nav1.5
were unclear. We have now found that the chronic ISO and AngII treatment decrease Nav1. Figure S4 ). These data suggest a possibility that calcium-mediated expression of Nedd4-2 may participate in Nav1.5 downregulation in the hypertrophied cardiomyocytes. While caution must be taken when using experimental data obtained in cultured cells to interpret observations in vivo animals, our data suggest a possibility that the altered calcium homoeostasis in heart failure may decrease Nav1.5 via increasing Nedd4-2 expression. Further studies using the Nedd4-2 knockout/down animal model are needed to establish a direct mechanistic link.
In conclusion, our work demonstrates that calcium increases Nedd4-2 expression and enhances the interaction between Nedd4-2 and Nav1.5, consequently reducing Nav1.5 membrane density via Nedd4-2-mediated ubiquitination (as illustrated in Fig. 8 ). Nav1.5 is downregulated and accompanied by increased co-localization with Nedd4-2 and ubiquitin in a volume-overload HF model. These observations suggest a role of Nedd4-2 in Nav1.5 regulation in heart failure. Figure 8 Proposed scheme illustrating that calcium reduces Nav1.5 by increasing Nedd4-2, a possible mechanism in HF. Increased Ca 2+ 'leakage' through malfunctioned RyR2 channel from sarcoplasmic reticulum (SR), increased Ca 2+ entry from extracellular space via L-type calcium channel (LTCC) and reduced SR Ca 2+ uptake by sarcoplasmic reticulum Ca 2+ ATPase (SERCA) elevated cytosolic Ca 2+ level and enhance Nedd4-2 expression and function. The WW domain of Nedd4-2 binds to the PY motif of Nav1.5 to initiate Nedd4-2-mediated ubiquitination and internalization which may be either degraded or recycled back to the membrane.
Limitations
This study has two main limitations: (a) the altered calcium handling in HF is very complicated and could not be completely mimicked by in vivo experiment models. We use ionomycin or thapsigargin to increase or BAPTA-AM to decrease calcium concentration, and those are different from HF and may activate other cellular process. (b) In vivo studies of the functional role of Nedd4-2-mediated downregulation of Nav1.5 in HF using Nedd4-2 knockout models are needed. Drugs that remedy the altered calcium homoeostasis in HF should also be used to test the effect of calcium on Nedd4-2 expression in vivo.
Materials and methods
In vivo animal studies
(1) Volume-overload HF model. Male Sprague-Dawley rats (weighing 140-160 g) were obtained from the Laboratorial Animal Center of Xi'an Jiaotong University (Xi'an, Shaanxi, China) and randomly assigned to two groups, sham operation (SO) and HF. The volume-overload HF model was established as reported previously with some modifications. 43, 44 Briefly, the rats were anesthetized by intraperitoneal injection of sodium pentobarbital (40-45 mg kg À1 body weight). The depth of anaesthesia was monitored by the absence of pedal withdrawal upon toe pinching and the loss of corneal reflex. The abdominal cavity was opened along the linea alba (about 4 cm), and the shunts were achieved by puncturing the aorta with vena cava. The abdominal incision was sutured, and the rats were allowed to recover. Rats were given buprenorphine (0.1 mg kg
À1
) subcutaneously every 8-12 h for the initial 24 h for analgesia and minimizing pain caused by surgical operations. The rats were then maintained in cages at 21 AE 1°C with 12-h light/dark cycles. Rats in the SO group had a similar operation without establishing a fistula. When the volume-overload rat HF model was successfully established, rats were killed by pentobarbital sodium (200 mg kg À1 , i.p.), and the hearts were excised for further analysis. All procedures were approved by the Care of Experimental Animals Committee of Xi'an Jiaotong University, and the investigation conforms to the US National Institutes of Health guidelines (Guide for the Care and Use of Laboratory Animals). (2) Echocardiography. Twelve weeks post-surgery, the rats were anaesthetized by inhalation of 2% isoflurane and placed in a supine position on a hotplate. Then, the transthoracic echocardiography was performed to monitor the thickness of left ventricular wall, and the systolic and diastolic cardiac function using an iE33 Imaging System (Philips Healthcare, Andover, MA) equipped with a 30-MHz microprobe. 45 (3) Isolation of adult rat cardiomyocytes. Single cardiomyocytes were isolated as described previously. 44 Briefly, the rats were anaesthetized with sodium pentobarbital (40-45 mg kg
, i.p) and anticoagulated with heparin sodium (400 IU kg À1 , i.p.). The hearts were quickly excised by thoracotomy, cannulated via a Langendorff perfusion apparatus and then digested using 179 IU mL À1 collagenase type I (Sigma-Aldrich), 0.01% protease (Sigma-Aldrich) and 0.06% bovine serum albumin dissolved in Tyrode's solution at 37°C. The isolated cardiomyocytes were stored in Kraftbr€ uhe (KB) solution at room temperature (22-24°C) . At least 80% of the isolated cardiomyocytes were rod-shaped with clear striation. (4) Proteins from whole-cell or membrane-rich fraction were extracted using RIPA buffer or the Mem-PER Eukaryotic Membrane Protein Extraction Reagent Kit (Thermo Scientific, Waltham, MA, USA), respectively, and separated by 8% SDS-PAGE and transferred to PVDF membranes (Millipore, Billerica, MA, USA). The membranes were probed with either anti-Nav1.5 (Alomone, Jerusalem, Israel), Cav1.2 (Alomone), KCNQ1 (Santa Cruz Biotechnology), Kv1.5 (Santa Cruz Biotechnology), Kv4.3 (Santa Cruz Biotechnology) or anti-Nedd4-2 (Cell Signaling Technology) antibody, followed by horseradish peroxidase-conjugated secondary antibody (goat anti-rabbit IgG-HRP, Santa Cruz Biotechnology). Finally, the proteins were detected using ECL (Bio-Rad Hercules, CA, USA) on a chemiluminescence system (ChemiDoc XRS, Bio-Rad). Actin (antibody from Santa Cruz Biotechnology) was used for protein normalization. All band intensities were quantified by densitometry.
(4) Co-immunoprecipitation (Co-IP) analysis. For Co-IP detection, 0.5 mg of protein in 0.5 mL lysis buffer was incubated with either anti-Nav1.5 (Santa Cruz Biotechnology), anti-HA (Sino Biological, Shanghai, China), anti-ubiquitin (Sigma-Aldrich) or anti-GAPDH (Santa Cruz Biotechnology) antibodies at 4°C for 4 h, followed by overnight incubation with protein A/G Plus-agarose beads (Santa Cruz Biotechnology) at 4°C on a rotator. After they were washed three times with RIPA buffer, Currents were digitized at a sampling rate of 10 kHz and filtered at 2 or 5 kHz (Digidata 1440A, Axon Instruments). I Na was recorded by 20-ms step depolarizations to different potentials between À80 and +60 mV from a holding potential of À140 mV. The voltage dependence of steady-state inactivation was obtained by a 25-ms test pulse to À10 mV after a pre-pulse of 500-ms at different membrane potentials (Vm). Recovery from inactivation was analysed using the double-pulse protocol at 0.1 Hz. From a holding potential of À90 mV, the membrane was first pulsed to À30 mV for 1 s to induce inactivation (P1). The membrane was then repolarized to À90 mV for varying periods before the second pulse to À30 mV for 50 ms was applied. The current amplitudes upon P2 were plotted against P1-P2 intervals. Data were analysed using Clampfit 10.2 (Axon Instruments).
Statistical analysis
All data are presented as the meanAE standard error of the mean. Two-tailed independent Student's t-tests were used to test the statistical significance between two groups. One-way analysis of variance was used for multiple comparisons with the Bonferroni test for post hoc testing. The null hypothesis was rejected for P < 0.05.
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